A5074076396- Cardiovascular Function and Risk Factors
- Atrial Fibrillation Management and Outcomes
- Cardiac Imaging and Diagnostics
- Blood Pressure and Hypertension Studies
- Diabetes Treatment and Management
- Healthcare Operations and Scheduling Optimization
- Peroxisome Proliferator-Activated Receptors
- Lipoproteins and Cardiovascular Health
- Sepsis Diagnosis and Treatment
- Hemodynamic Monitoring and Therapy
- Credit Risk and Financial Regulations
- Risk Management in Financial Firms
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Metabolism, Diabetes, and Cancer
Zhongshan Hospital
2022-2024
National Clinical Research Center for Digestive Diseases
2024
Fudan University
2020-2024
Huashan Hospital
2020-2024
The First Affiliated Hospital, Sun Yat-sen University
2022
Sun Yat-sen University
2022
Creative Commons
2020
Abstract Background Three dimensional speckle tracking echocardiography (3D STE) is a novel technique combining 3D and analysis. STE software dedicated to the left atrium (LA) was recently available. Our study aimed assess (1) atrial fibrillation (AF) related LA morpho-functional remodeling using (2) value of function parameters in identifying paroxysmal AF (PAF). Methods One hundred thirty-nine PAF, 109 persistent (Per-AF) 59 non-AF subjects underwent STE. phasic volumes total emptying...
Abstract Backgrounds 20-30% atrial fibrillation (AF) may result in heart failure (HF). Noninvasive left ventricle myocardial work (LVMW) is a fairly new method for detecting LV function. We aimed to evaluate whether LVMW could detect the change function paroxysmal (PAF) and predict HF incident. Methods In this prospective cohort study, 146 PAF subjects 63 non-PAF matched by age gender set as controls were enrolled. parameters, including global index, constructive work, wasted (GWW)...
To investigate the effect of first 24-hour (24-h) urine output (UO) on in-hospital and 1-year mortality in patients admitted to intensive care units due acute myocardial infarction.
Objectives: This study aimed to investigate the association between metabolic syndrome (MetS) components and chronic kidney disease (CKD) in hypertension of different low-density lipoprotein cholesterol (LDL-C) levels. Methods: national cross-sectional was conducted hospitals 24 cities China comprised 4792 eligible hypertensive participants with a recorded creatinine level 2017 2018. All underwent clinical survey assessment were required provide biomedical reports within 1 year from their...
目前已有多个研究证实新型口服降糖药物钠-葡萄糖共转运体2（SGLT2）抑制剂可在安全降糖的基础上有效降低糖尿病患者因心力衰竭（心衰）住院以及心血管、全因死亡风险。最近发表的DAPA-HF研究结果显示，无论患者是否存在糖尿病，达格列净均可显著降低左心室射血分数<40%的慢性心衰患者心衰恶化及心血管死亡风险的复合终点。该研究结果使SGLT2抑制剂从降糖药物"跨界"到心衰治疗领域。该文就有关SGLT2抑制剂主要的临床研究的设计及结论进行了论述与比较，提出了SGLT2抑制剂可通过改善肾脏神经内分泌、降低肾素-血管紧张素-醛固酮系统活性来降低心血管终点事件的假说，并对SGLT2抑制剂改善心血管病临床结局的其他可能机制进行了阐述。.